Teresa García-Berrocoso Selected Research

Teresa García-Berrocoso Research Topics

Disease

34	Stroke (Strokes) 11/2023 - 08/2010
18	Ischemic Stroke 11/2023 - 11/2010
9	Inflammation (Inflammations) 01/2021 - 12/2010
8	Brain Ischemia (Cerebral Ischemia) 11/2023 - 11/2010
4	Infections 11/2017 - 01/2013
3	Infarction (Infarctions) 08/2021 - 11/2010
3	Ischemia 08/2021 - 02/2016
2	Diabetes Mellitus 01/2018 - 01/2013
2	Hypertension (High Blood Pressure) 01/2017 - 02/2014
2	Hemorrhagic Stroke 01/2017 - 08/2012
2	Cerebral Hemorrhage 12/2016 - 01/2016
2	Embolic Stroke 05/2015 - 08/2010
1	Hypothermia 11/2023
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018
1	Sepsis (Septicemia) 11/2017
1	Atrial Fibrillation 01/2017
1	Multiple Sclerosis 01/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2016
1	Arthritis (Polyarthritis) 01/2016
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2016
1	Leukemia 05/2014
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2014
1	Transient Ischemic Attack 01/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Atherosclerosis 01/2012
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Neuroinflammatory Diseases 12/2010
1	Brain Injuries (Brain Injury) 12/2010

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 11/2023 - 08/2010
11	Proteins (Proteins, Gene)FDA Link 08/2021 - 08/2010
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2016 - 12/2010
4	CytokinesIBA 10/2016 - 12/2010
3	ProteomeIBA 01/2018 - 11/2010
3	C-Reactive ProteinIBA 05/2017 - 10/2016
3	pro-brain natriuretic peptide (1-76)IBA 01/2017 - 12/2013
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 12/2013
3	ChemokinesIBA 01/2016 - 12/2010
2	Natriuretic PeptidesIBA 05/2015 - 12/2013
2	fibrin fragment D (D-dimer)IBA 08/2012 - 08/2010
1	Fatty Acid-Binding ProteinsIBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 11/2023
1	MicroRNAs (MicroRNA)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	EndostatinsIBA 01/2017
1	Galectin 3 (LGALS3)IBA 12/2016
1	Troponin IIBA 09/2016
1	TroponinIBA 09/2016
1	Oxygen (Dioxygen)IBA 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	IsotopesIBA 02/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Neuroprotective AgentsIBA 01/2016
1	Receptor for Advanced Glycation End ProductsIBA 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	ThrombospondinsIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Factor VII (Proconvertin)IBA 01/2016
1	EnzymesIBA 01/2016
1	Chondroitin Sulfate ProteoglycansIBA 01/2016
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	DisintegrinsIBA 01/2016
1	AntibodiesIBA 01/2016
1	Cell-Free Nucleic AcidsIBA 01/2016
1	Glial Fibrillary Acidic ProteinIBA 01/2016
1	AntigensIBA 01/2016
1	IntegrinsIBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	Interleukin-33IBA 10/2015
1	Interleukin-4 (Interleukin 4)IBA 10/2015
1	chitotriosidaseIBA 10/2014
1	Interleukin-6 (Interleukin 6)IBA 09/2014
1	Interleukin-12 Subunit p40IBA 05/2014
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 05/2014
1	beta-DefensinsIBA 05/2014
1	Plasminogen Activator Inhibitor 1IBA 05/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014
1	4-(fluoromethyl)phenyl phosphate (FMPP)IBA 02/2014
1	Cystatin AIBA 12/2013
1	GelsolinIBA 12/2013
1	InterferonsIBA 01/2013
1	Interleukin-13IBA 01/2013
1	SecretagoginsIBA 08/2012
1	Caspase 3 (Caspase-3)IBA 08/2012
1	cerebellinIBA 08/2012
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2012
1	GelsIBA 11/2010
1	collapsin response mediator protein-2IBA 11/2010
1	Adenosine Triphosphatases (ATPase)IBA 11/2010

Therapy/Procedure

6	Therapeutics 01/2018 - 12/2010
3	Secondary Prevention 01/2020 - 08/2010
2	Lasers (Laser) 01/2018 - 11/2010
1	Induced Hypothermia 11/2023
1	Thrombectomy 01/2016
1	Immunomodulation 10/2015